Isordil (Isosorbide Dinitrate)

After administration, isosorbide dinitrate is converted to nitric oxide, which activates guanylate cyclase, raises cyclic GMP levels, and causes smooth‑muscle relaxation in veins and arteries, lowering preload, afterload, and myocardial oxygen demand.

The dose of Isordil is individualized by the prescribing clinician based on the patient’s condition, response, and tolerance. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for isosorbide dinitrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified health professional.

To order Isordil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Isordil belongs to the nitrate class, offering rapid onset of vasodilation, whereas beta‑blockers and calcium‑channel blockers act through different mechanisms. Nitrates are especially useful for acute relief of angina, but tolerance can develop with continuous use, a factor less common with other classes.

Isordil should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to excessive heat.

Isordil is supplied as a sublingual tablet. The tablet is placed under the tongue and allowed to dissolve completely without swallowing, providing rapid absorption into the bloodstream for quick symptom relief.

The most serious risks include severe hypotension, syncope, and rare allergic reactions such as anaphylaxis. Patients should be educated to recognize signs of dangerously low blood pressure and seek immediate medical attention if they occur.

Isordil is contraindicated in patients who have taken phosphodiesterase‑5 inhibitors within the past 24‑48 hours, those with known hypersensitivity to nitrates, and individuals with severe anemia or uncontrolled hypotension.